Racciatti, D, Dalessandro, M, Delle Donne, L et al. · International journal of immunopathology and pharmacology · 2004 · DOI
This study looked at immune system cells in people with ME/CFS to see if there were differences compared to healthy people. Researchers tested blood samples from 139 ME/CFS patients and 36 healthy controls, examining specific types of white blood cells. They found that people with ME/CFS had lower counts of certain immune cells, suggesting the immune system may play a role in causing or maintaining the condition.
This research provides objective biological evidence that immune system abnormalities are associated with ME/CFS, potentially validating patient experiences of an underlying physiological dysfunction. The finding that different ME/CFS subgroups show distinct immune profiles suggests that the condition may have multiple immune mechanisms, which could eventually inform more targeted treatment strategies.
This study cannot establish whether immune changes cause ME/CFS or result from it, as cross-sectional designs measure only a single time point. The findings do not prove that immune dysfunction is the primary driver of symptoms, nor do they explain the specific mechanisms by which these cellular changes produce fatigue and disability. Additionally, the study does not establish whether these immune markers could serve as diagnostic tests or predict treatment response.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →